Market Research on Battling cancer with AI


The most diagnosed cancer in the United States, excluding nonmelanoma skin cancer, is now breast cancer, overtaking lung cancer in recent statistics. It is, fortunately, possible to utilize an innovative new tool to help clinicians deal with this sudden increase in demand, while at the same time providing them with an unprecedented level of accuracy. According to the market database, radiologists can read mammograms more than 50% faster with ProFound AI, which uses deep-learning artificial intelligence (AI). While reducing the number of false positives and unnecessary call-backs, which are stressful for women.

Register now to get free 10 year market forecast of Battling cancer with Artificial Intelligence AI market research report

Recent advances in artificial intelligence (AI) are helping to detect, classify, and monitor different types of tumors. Deep learning algorithms can be used to perform automated analysis of mammographic and histologic images. Advanced machine learning methods can be used to interoperate with large amounts of data resulting from a digitalized mammogram or full-slide images. The resulting rapid analysis of every patch of tissue yields a quicker and more sensitive diagnosis than that provided by human experts. Meanwhile, the use of cancer cell exosomes, which are extracellular vesicles released into the bloodstream by cancer cells, is being explored as a biomarker.

In theory, nanogenomicas can generate a profile of each breast tumor sub-type, estrogen receptor status, and potential metastasis sites. An AI program can then match the miRNA and biomolecule compositions of serum samples of suspected patients to templates on a laboratory instrument with the AI program.

According to the market database, numerous software applications have been used for years to assist in the screening and diagnosis of breast cancer. Unfortunately, these programs are limited in their ability to detect, classify, treat, and monitor different types of breasts tumors. Thus, recent advancements in computer science and artificial intelligence (AI) are aimed at addressing these limitations. As opposed to previous detection and diagnostic software, AI utilizes algorithms like reasoning-based cognition in the human brain. The women in the study were anonymously identified using an AI model.


Microsoft’s involvement and innovations 

Microsoft is leveraging machine learning and natural language processing to help oncologists select the most effective, individualized cancer treatment for their patients. In an innovation called Inner Eye, machine learning is combined with computer vision to provide radiologists with a deeper understanding of how tumors are progressing. The Addenbrooke’s Hospital in Cambridge uses it to develop AI models that automatically highlight tumors and healthy organs on scans of patients. According to the market database, medical professionals will be able to view the genomes of individual cancer cells as a result of a collaboration between Battling Cancer ai and Microsoft Canada. Oncologists will be able to predict how individual tumor cells will respond to chemotherapy based on this level of detail.

Market database states that the Bio Model Analyzer (BMA), a tool developed by Microsoft, helps biologists’ model how cells communicate and interact with each other. The BMA is useful for detecting cancer early and understanding how to treat it more effectively by predicting which treatments will be most effective at what stage. It has been used by Microsoft and AstraZeneca to analyze drug interactions and resistance in patients with specific types of leukemia.

As part of Microsoft’s Project Hanover, the Jackson Laboratory – an independent nonprofit biomedical research institution, developed a tool in collaboration with computer scientists to help the global medical and scientific communities. According to the market database, it is to maintain a steady flow of genomic data. A searchable database called the Clinical Knowledgebase enables experts to manage, sort, and interpret complex genomic information. It is to improve patient outcomes and share information about clinical trials and treatment options. Microsoft AI technology can read complex medical and research documents and highlight their important points. The goal of Project Hanover is to analyze all the fragmented information to find the most relevant pieces of information. It allows tumor specialists to focus more on determining the best treatment plan for patients.

Global Market Database is your one-source destination for all of your market research needs. It covers the Battling cancer with AI. Login to the global market database and access a 10-year market forecast, regional market forecast and top 20 country market analysis for the same.